NANOphotonic DEvice for Multiple therapeutic drug monitoring

The project involves the development of a Point-of-care therapeutic monitoring of immunosuppressants and related metabolites in transplant patients. In particular, it will be developed an optical chip / microfluidic and a suitable readout system that will enable continuous monitoring for 48H and related metabolites of immunosuppressants in transplant patients.

FundsEuropean Union

Type:  VII Framework Programme

Period of activity: 2012 -2016

Responsible for CNR-IREA

Romeo Bernini